Martin, 1994 - Google Patents
The expression and metal affinity purification of single-chain antibodiesMartin, 1994
View PDF- Document ID
- 366539913209118031
- Author
- Martin S
- Publication year
- Publication venue
- PQDT-Global
External Links
Snippet
Single-chain antibody fragments (ScFv's) which were originally derived from the anticancer antibody B72. 3, were genetically altered in order to facilitate their purification by immobilized metal affinity chromatography (IMAC). Metal-binding tails comprising two or five …
- 229910052751 metal 0 title abstract description 103
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
- A61K47/48507—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment the modifying agent being a well defined antibody or immunoglobulin bearing at least one antigen-binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6121424A (en) | Multivalent antigen-binding proteins | |
| EP0617706B1 (en) | Multivalent antigen-binding proteins | |
| US5869620A (en) | Multivalent antigen-binding proteins | |
| CA1341411C (en) | Method for producing fv fragments in eukaryotic cells | |
| EP1752465B1 (en) | Linear VH-CH1-VH-CH1 heavy chain antibody fragment | |
| King et al. | Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab'fragment | |
| EP0640130B1 (en) | Chimeric multivalent protein analogues and methods of use thereof | |
| CN108602878A (en) | C-terminal lysine conjugated immunoglobulin | |
| IE900493L (en) | Cross-linked antibodies and processes for their preparation | |
| WO1993021319A1 (en) | HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES | |
| JPH03501440A (en) | immunoreactive heterochain antibody | |
| EP4130046A1 (en) | Platform for constructing multispecific antibody | |
| CN102936283B (en) | Anti-human CD146 monoclonal antibodies, compositions containing anti-human CD146 monoclonal antibodies, and soluble CD146 detection method | |
| JPH02501985A (en) | Selective removal of immune complexes | |
| Furie et al. | Antibodies to the unfolded form of a helix-rich region in staphylococcal nuclease | |
| Tai et al. | Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers | |
| Baumann et al. | Indirect immobilization of recombinant proteins to a solid phase using the albumin binding domain of streptococcal protein G and immobilized albumin | |
| Martin | The expression and metal affinity purification of single-chain antibodies | |
| Proudfoot et al. | Purification of recombinant chimeric B72. 3 Fab′ and F (ab′) 2 using streptococcal protein G | |
| Zack et al. | Somatically generated mouse myeloma variants synthesizing IgA half-molecules. | |
| CN105017414A (en) | Recombinant Pro-A and/or G coupled polysaccharide affinity medium and application thereof | |
| EP0686696A1 (en) | Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant Hepatitis B Virus Surface Antigen | |
| CN100402554C (en) | Preparation and application of testis-specific protein 50 human antibody | |
| Casalvilla et al. | A bacterial single-chain Fv antibody fragment that inhibits binding of its parental anti-E-selectin monoclonal antibody to activated human endothelial cells | |
| Pimentel et al. | Hexa-histidine tag as a novel alternative for one-step direct labelling of a single-chain Fv antibody fragment with 99mTc |